Wide Ranks

LSB

LakeShore Biopharma Co., Ltd

2.98

Top Statistics
Market Cap 56 M Forward PE -11.93 Revenue Growth 27.70 %
Current Ratio 1.13 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -75.59 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.7440 Enterprise / Revenue 0.4100 Price To Sales Trailing12 Months 0.0993
Profitability
Profit Margins -75.59 % Operating Margins -68.83 %
Balance Sheet
Total Cash 246 M Total Cash Per Share 12.91 Total Debt 424 M
Total Debt To Equity 72.53 Current Ratio 1.13 Book Value Per Share 30.76
All Measures
Short Ratio 64.00 % Message Board Id finmb_207278456 Shares Short Prior Month 7960
Return On Equity -0.6599 City Beijing Uuid 6ea6688c-c997-39eb-8624-eef718719215
Previous Close 3.16 First Trade Date Epoch Utc 1 B Book Value 30.76
Beta 0.7400 Total Debt 424 M Volume 14472
Price To Book 0.0970 Last Split Date 1 B Fifty Two Week Low 1.88
Total Cash Per Share 12.91 Total Revenue 573 M Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -68.83 %
Net Income To Common -433464864 Ask 3.02 Short Percent Of Float 0.0134
Implied Shares Outstanding 20 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 21740 Average Volume10days 21740 Total Cash 246 M
Next Fiscal Year End 1 B Revenue Per Share 53.63 Held Percent Insiders 0.8135
Ebitda Margins -55.09 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 3.16 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.95 Open 3.30
Free Cashflow -216485936 Dividend Yield 0.00 % Return On Assets -0.1385
Time Zone Short Name EST Trailing Eps -5.58 Day Low 2.90
Address1 Building No. 2 Shares Outstanding 19 M Price Hint 4
Target High Price 0.0000 Website https://www.ysbiopharm.com 52 Week Change -0.4671
Average Volume 41529 Forward Eps -0.2500 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 86.40 % Last Split Factor 1:10
Regular Market Day High 3.30 Is_sp_500 False Profit Margins -75.59 %
Debt To Equity 72.53 Fifty Two Week High 11.20 Day High 3.30
Shares Short 47525 Regular Market Open 3.30 Industry Key biotechnology
Bid 3.75 Earnings Growth 0.00 % Enterprise To Revenue 0.4100
Revenue Growth 27.70 % Shares Percent Shares Out 0.0025 Operating Cashflow -295229600
Currency USD Time Zone Full Name America/New_York Market Cap 56 M
Is_nasdaq_100 False Zip 102629 Quote Type EQUITY
Industry Biotechnology Long Name LakeShore Biopharma Co., Ltd Regular Market Day Low 2.90
Held Percent Institutions 0.0169 Current Price 2.98 Address2 38 Yongda Road Daxing Biomedical Industry Park Daxing District
Enterprise To Ebitda -0.7440 Financial Currency CNY Current Ratio 1.13
Gross Margins 67.33 % Industry Disp Biotechnology Country China
Float Shares 3 M Two Hundred Day Average 5.77 Enterprise Value 235 M
Price To Sales Trailing12 Months 0.0993 Forward PE -11.93 Regular Market Volume 14472
Ebitda -315903072 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
LakeShore Biopharma Co.

, Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer.

The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the  treatment of chronic HBV infection; and  PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials.

It operates in China, Singapore, the United States, and the Philippines.

The company was formerly known as YS Biopharma Co.

, Ltd.

and changed its name to LakeShore Biopharma Co.

, Ltd in May 2024.

The company was founded in 2002 and is based in Beijing, China.